Viewing Study NCT01601093


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-27 @ 7:59 AM
Study NCT ID: NCT01601093
Status: SUSPENDED
Last Update Posted: 2019-07-05
First Post: 2012-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module